SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001213900-22-044453
Filing Date
2022-08-03
Accepted
2022-08-03 16:10:43
Documents
62
Period of Report
2022-06-30

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT f10q0622_inmunebio.htm   iXBRL 10-Q 562067
2 CERTIFICATION f10q0622ex31-1_inmunebio.htm EX-31.1 9633
3 CERTIFICATION f10q0622ex31-2_inmunebio.htm EX-31.2 9547
4 CERTIFICATION f10q0622ex32-1_inmunebio.htm EX-32.1 4680
5 CERTIFICATION f10q0622ex32-2_inmunebio.htm EX-32.2 4490
  Complete submission text file 0001213900-22-044453.txt   3709383

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE inmb-20220630.xsd EX-101.SCH 58107
7 XBRL CALCULATION FILE inmb-20220630_cal.xml EX-101.CAL 29047
8 XBRL DEFINITION FILE inmb-20220630_def.xml EX-101.DEF 197240
9 XBRL LABEL FILE inmb-20220630_lab.xml EX-101.LAB 444906
10 XBRL PRESENTATION FILE inmb-20220630_pre.xml EX-101.PRE 208943
56 EXTRACTED XBRL INSTANCE DOCUMENT f10q0622_inmunebio_htm.xml XML 349877
Mailing Address 225 NE MIZNER BLVD, SUITE 640 BOCA RATON FL 33432
Business Address 225 NE MIZNER BLVD, SUITE 640 BOCA RATON FL 33432 8589643720
Inmune Bio, Inc. (Filer) CIK: 0001711754 (see all company filings)

IRS No.: 475205835 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38793 | Film No.: 221132674
SIC: 2836 Biological Products, (No Diagnostic Substances)